tiprankstipranks
Dimed S.A. Distribuidora de Medicamentos (BR:PNVL3)
:PNVL3
Brazil Market
PNVL3
Dimed S.A. Distribuidora de Medicamentos
RESEARCH TOOLSreports

Dimed S.A. Distribuidora de Medicamentos (PNVL3) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

PNVL3 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Dimed
S.A. Distribuidora de Medicamentos
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PNVL3 Stock 12 Month Forecast

There Are No Analyst Ratings for BR:PNVL3 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

PNVL3 Financial Forecast

PNVL3 Earnings Forecast

Next quarter’s earnings estimate for PNVL3 is $0.34 with a range of $0.34 to $0.34. The previous quarter’s EPS was $0.27. PNVL3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year PNVL3 has Performed in-line its overall industry.
Next quarter’s earnings estimate for PNVL3 is $0.34 with a range of $0.34 to $0.34. The previous quarter’s EPS was $0.27. PNVL3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year PNVL3 has Performed in-line its overall industry.

PNVL3 Sales Forecast

Next quarter’s sales forecast for PNVL3 is $1.57B with a range of $1.57B to $1.57B. The previous quarter’s sales results were $1.51B. PNVL3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year PNVL3 has Performed in-line its overall industry.
Next quarter’s sales forecast for PNVL3 is $1.57B with a range of $1.57B to $1.57B. The previous quarter’s sales results were $1.51B. PNVL3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year PNVL3 has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

PNVL3 Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

PNVL3 Stock Forecast FAQ

What is BR:PNVL3’s average 12-month price target, according to analysts?
Currently, no data Available
What is BR:PNVL3’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for BR:PNVL3, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Dimed S.A. Distribuidora de Medicamentos a Buy, Sell or Hold?
      Currently, no data Available
      What is Dimed S.A. Distribuidora de Medicamentos’s share price target?
      Currently, no data Available
      What do analysts say about Dimed S.A. Distribuidora de Medicamentos?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Dimed S.A. Distribuidora de Medicamentos?
      To buy shares of BR:PNVL3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.